<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05125406</url>
  </required_header>
  <id_info>
    <org_study_id>2019-16</org_study_id>
    <nct_id>NCT05125406</nct_id>
  </id_info>
  <brief_title>Prevention of ICU-Related Anxiety in Lung Transplantation by Virtual Reality Therapy - PIRAT Study</brief_title>
  <acronym>PIRAT</acronym>
  <official_title>Prevention of ICU-Related Anxiety in Lung Transplantation by Virtual Reality Therapy - PIRAT Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      ICU patients frequently face complicated recovery processes, including long-term anxiety&#xD;
      disorders. Lung transplantation (LTx) offers people with terminal respiratory conditions both&#xD;
      the hope of prolonged survival and a better quality of life related to health. Among the&#xD;
      disorders usually encountered in the postoperative period of LTx are anxio-depressive&#xD;
      disorders. These anxiety disorders affect the quality of life related to health and&#xD;
      compromise the follow-up of the patient by phenomenon of psychological disinvestment. Other&#xD;
      psychological disorders are also anchored in the patient's experience of this post-surgical&#xD;
      ICU period (ie, depressive episodes and/or, at a distance, post-traumatic stress disorder&#xD;
      (PTSD). Various models of management of anxio-depressive disorders and PTSD are proposed in&#xD;
      the literature. To our knowledge, while many of them have shown their efficiency in the&#xD;
      curative management of disorders, few have demonstrated their effectiveness in preventing&#xD;
      them. Exposure therapies using virtual reality (ETVR) have in the past demonstrated their&#xD;
      effectiveness in many areas of psychiatry. In our study, experimental arm patients will be&#xD;
      offered ETRV support with a virtual reality headset. A scenario with progressively increasing&#xD;
      stress levels linked to the ICU environment and different situational contexts (alarms, etc.)&#xD;
      will be presented to patients. This habituation to the potentially anxiety context of ICU&#xD;
      will reduce the occurrence of psycho-cognitive disorders by progressive extinction&#xD;
      phenomenon.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 8, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2024</completion_date>
  <primary_completion_date type="Anticipated">February 8, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Spielberger state trait anxiety inventory for adults</measure>
    <time_frame>3 months post lung transplantation</time_frame>
    <description>The State-Trait Anxiety Inventory (STAI) has been used extensively in research and clinical practice. It comprises separate self-report scales for measuring state and trait anxiety. The S-Anxiety scale (STAI Form Y-1) consists of twenty statements that evaluate how respondents feel &quot;right now, at this moment.&quot; The T-Anxiety scale (STAI Form Y-2) consists of twenty statements that assess how people generally feel.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression scale (HADS)</measure>
    <time_frame>3 and 6 months post lung transplantation</time_frame>
    <description>The Hospital Anxiety and Depression Scale (HADS) measure anxiety and depression in a general medical population of patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Impact of Event Scale -Revised</measure>
    <time_frame>3 and 6 months post lung transplantation</time_frame>
    <description>The IES-R is a solid measure of post-trauma phenomena and Posttraumatic Stress Disorder.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-traumatic stress disorder Checklist Scale (PCLS)</measure>
    <time_frame>3 and 6 months post lung transplantation</time_frame>
    <description>The IES-R is a solid measure of post-trauma phenomena and Posttraumatic Stress Disorder.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Transplantation, Lung</condition>
  <condition>Depression, Anxiety</condition>
  <condition>PTSD</condition>
  <arm_group>
    <arm_group_label>Exposure therapy using Virtual Reality (ETVR)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No exposure therapy with Virtual Reality.</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exposure therapy with Virtual Reality.</intervention_name>
    <description>Experimental arm patients will be offered Exposure therapy with Virtual Reality (ETRV) support with a virtual reality headset. A scenario with progressively increasing stress levels linked to the ICU environment and different situational contexts (alarms, etc.) will be presented to patients. This habituation to the potentially anxiety context of ICU will reduce the occurrence of psycho-cognitive disorders by progressive extinction phenomenon.</description>
    <arm_group_label>Exposure therapy using Virtual Reality (ETVR)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age above 18 years&#xD;
&#xD;
          -  Registration on the lung transplant waiting list&#xD;
&#xD;
          -  Signature of consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Minor patient, pregnant or breastfeeding woman, or not affiliated to the social&#xD;
             security scheme&#xD;
&#xD;
          -  Patient under guardianship or curatorship&#xD;
&#xD;
          -  Patient with a history of mental illness&#xD;
&#xD;
          -  Patient not mastering the French language&#xD;
&#xD;
          -  Patient deprived of liberty&#xD;
&#xD;
          -  Patient carrying a transplanted organ (liver, kidney, heart ...)&#xD;
&#xD;
          -  Lung re-transplantation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>BENJAMIN COIFFARD, MD</last_name>
    <phone>+33 491964355</phone>
    <email>Benjamin.COIFFARD@ap-hm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>EMILIE GARRIDO-PRADALIE, Study Director</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assistance Publique Des HÃ´pitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BENJAMIN COIFFARD, MD</last_name>
      <phone>+33 491964355</phone>
      <email>Benjamin.coiffard@ap-hm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 8, 2021</study_first_submitted>
  <study_first_submitted_qc>November 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2021</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

